DekaBank Deutsche Girozentrale
KYTH

DekaBank Deutsche Girozentrale’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-13,000
Closed -$975K – 1195
2015
Q3 		$975K Buy
13,000
+500
+4% +$37.3K 0.01% 558
2015
Q2 		$941K Buy
12,500
+1,900
+18% +$102K 0.01% 578
2015
Q1 		$532K Sell
10,600
-1,600
-13% -$67.2K 0.01% 699
2014
Q4 		$421K Sell
12,200
-1,100
-8% -$38.4K 0.01% 722
2014
Q3 		$436K Buy
13,300
+300
+2% +$10.6K 0.01% 685
2014
Q2 		$499K Buy
13,000
+1,100
+9% +$38.4K 0.01% 599
2014
Q1 		$473K Buy
+11,900
New +$532K 0.01% 582

DekaBank Deutsche Girozentrale's KYTH Position: Q4 2015 in Review

DekaBank Deutsche Girozentrale sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 13,000 shares — an estimated $975K sold.

DekaBank Deutsche Girozentrale first reported a position in KYTH in Q1 2014 and held it in 7 quarters. The position peaked at $975K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • DekaBank Deutsche Girozentrale reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 13,000 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $975K.
  • DekaBank Deutsche Girozentrale first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 7 quarters.
  • DekaBank Deutsche Girozentrale's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $975K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2015, filed 25 Jan 2016.